Literature DB >> 7829226

Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin.

P J Wood1, J M Sansom, K Newell, I F Tannock, I J Stratford.   

Abstract

Nigericin is an ionophore which permits the influx of H+ ions into cells down a concentration gradient, thus reducing intracellular pH (pHi) when extracellular pH is low. The effects of nigericin on the pHi of solid murine tumours in vivo were examined using 31P magnetic resonance spectroscopy. Nigericin at 2.5 mg/kg i.p. reduced pHi by 0.2-0.3 pH unit in the KHT and RIF-I tumours but had no effect on pHi in the SCCVII/Ha tumour. In vitro studies have shown that reduced pH can increase the toxicity of melphalan. Therefore, the anti-tumour effect of combining nigericin with melphalan was also examined. Nigericin at 2.5 mg/kg i.p. given before various doses of melphalan resulted in substantial delay in growth of the RIF-I tumour over that induced by melphalan alone. This observation was confirmed by an in vivo/in vitro excision assay, where nigericin given before melphalan produced a 30-fold increase in cell killing. By contrast, no enhancement of melphalan-induced cell killing by nigericin was observed in the KHT and SCCVII/Ha tumours, using growth delay and in vivo/in vitro excision assays, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829226     DOI: 10.1002/ijc.2910600222

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.

Authors:  Wang-Yong Yang; Boris Breiner; Serguei V Kovalenko; Chi Ben; Mani Singh; Shauna N LeGrand; Qing-Xiang Amy Sang; Geoffrey F Strouse; John A Copland; Igor V Alabugin
Journal:  J Am Chem Soc       Date:  2009-08-19       Impact factor: 15.419

Review 2.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment.

Authors:  Jonathan W Wojtkowiak; Daniel Verduzco; Karla J Schramm; Robert J Gillies
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

3.  Inhibition of intracellular pH control and relationship to cytotoxicity of chlorambucil and vinblastine.

Authors:  C S Parkins; J A Chadwick; D J Chaplin
Journal:  Br J Cancer Suppl       Date:  1996-07

4.  Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms.

Authors:  Mohammed Albatany; Valeriy G Ostapchenko; Susan Meakin; Robert Bartha
Journal:  J Neurooncol       Date:  2019-08-07       Impact factor: 4.130

5.  The Monocarboxylate transporter inhibitor Quercetin induces intracellular acidification in a mouse model of Glioblastoma Multiforme: in-vivo detection using magnetic resonance imaging.

Authors:  Mohammed Albatany; Susan Meakin; Robert Bartha
Journal:  Invest New Drugs       Date:  2018-08-13       Impact factor: 3.850

6.  In vivo detection of acute intracellular acidification in glioblastoma multiforme following a single dose of cariporide.

Authors:  Mohammed Albatany; Alex Li; Susan Meakin; Robert Bartha
Journal:  Int J Clin Oncol       Date:  2018-05-10       Impact factor: 3.402

7.  Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).

Authors:  A Kuin; M Aalders; M Lamfers; D J van Zuidam; M Essers; J H Beijnen; L A Smets
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 8.  Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Authors:  Vivek Kaushik; Juan Sebastian Yakisich; Anil Kumar; Neelam Azad; Anand K V Iyer
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

9.  Repeated administration of inhibitors for ion pumps reduce markedly tumor growth in vivo.

Authors:  Igor Hrgovic; Zeljko Glavic; Zeljko Kovacic; Smaila Mulic; Lejla Zunic; Zlatko Hrgovic
Journal:  Med Arch       Date:  2014

10.  Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.

Authors:  Chad Myskiw; Jessica Piper; Rhiannon Huzarewich; Tim F Booth; Jingxin Cao; Runtao He
Journal:  Antiviral Res       Date:  2010-10-15       Impact factor: 10.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.